Suchergebnisse - "Talamonti, Marina"

PubPharm (6)

1

Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic : Risk analysis from the PSO-BIO-COVID observational study

enthalten in: Expert opinion on biological therapy | 2021

von Talamonti, M. | Galluzzo, M. | Chiricozzi, A. | +70

2

Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo

enthalten in: Cell cycle (Georgetown, Tex.) | 2020

von Campione, E. | Lanna, C. | Diluvio, L. | +12

3

Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients : a 24-month prospective multicentric study

enthalten in: Clinical rheumatology | 2018

von Chimenti, M. | Ortolan, A. | Lorenzin, M. | +11

4

HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients : A Retrospective Cohort Study

enthalten in: Molecular diagnosis & therapy | 2017

von Talamonti, M. | Galluzzo, M. | Zangrilli, A. | +6

5

Detection of adalimumab and anti-adalimumab levels by ELISA : clinical considerations

enthalten in: Drug development research | 2014

von Marinari, B. | Botti, E. | Bavetta, M. | +6

6

Long-term efficacy of adalimumab in generalized pustular psoriasis

enthalten in: The Journal of dermatological treatment | 2008

von Zangrilli, A. | Papoutsaki, M. | Talamonti, M. | +1

1
[1]